ENG and cancer: In fact, anti-endoglin antibodies are being evaluated as potential anti-cancer therapy and inhibit angiogenesis and metastasis in pre-clinical models (Bernabeu et al., 2023; González Muñoz et al., 2021; Paauwe et al., 2016; Uneda et al., 2009).